280+ Launches Later: Two Labs’ Insights on the Commercialization Journey

Today’s drug pipeline is in an interesting spot. In 2022, there were only 44 novel new drugs approved, down from 58 in 2020 and 60


What is Drug Price Transparency?

In 2015, the U.S. government passed the 21st Century Cures Act. In it was a provision called the ‘Open Act,’ designed to increase drug pricing transparency by requiring manufacturers to submit clinical trial results and detailed information on production and


Case Study: Mock Launch Support


A pharma client came to Two Labs for patient services mock launch testing prior to their first product commercialization in the U.S. market.

The goal was to ensure successful product launch upon FDA approval, with a well-tested, tightly integrated


Case Study: Post Launch Support


A biopharma client needed post-launch support for a patient services program for their breakthrough therapy and orphan drug designated immune-oncology product. 

Their external patient services model included a designated third-party partner that would handle:

  • case management
  • reimbursement
  • payor-facing activities

Post-Launch Optimization

Post-Launch Optimization: Because Your Product's Success Doesn't End with Launch

Whether you’re an emerging manufacturer putting the finishing touches on a new product launch or a small to mid-sized company whose products are outgrowing the post-launch support infrastructure you have in place, Two Labs provides expert consultative services to ensure


We’re here to support your success from clinical to commercial – and beyond.

How can we help you today?